GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » ODI Pharma AB (XSAT:ODI) » Definitions » Capital Expenditure

ODI Pharma AB (XSAT:ODI) Capital Expenditure : kr0.00 Mil (TTM As of Dec. 2024)


View and export this data going back to 2020. Start your Free Trial

What is ODI Pharma AB Capital Expenditure?

Cash flow for capital expenditures refers to the funds spent for a company to acquire or upgrade physical assets such as property, industrial buildings or equipment.

ODI Pharma AB's cash flow for capital expenditures for the three months ended in Dec. 2024 was kr0.00 Mil. Its cash flow for capital expenditures for the trailing twelve months (TTM) ended in Dec. 2024 was kr0.00 Mil.

ODI Pharma AB Capital Expenditure Historical Data

The historical data trend for ODI Pharma AB's Capital Expenditure can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ODI Pharma AB Capital Expenditure Chart

ODI Pharma AB Annual Data
Trend Jun19 Jun20 Jun21 Jun22 Jun23 Jun24
Capital Expenditure
Get a 7-Day Free Trial -0.02 - - - -

ODI Pharma AB Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Capital Expenditure Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

ODI Pharma AB Capital Expenditure Calculation

Cash flow for capital expenditures refers to the funds spent for a company to acquire or upgrade physical assets such as property, industrial buildings or equipment.

Capital Expenditure for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

ODI Pharma AB Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » ODI Pharma AB (XSAT:ODI) » Definitions » Capital Expenditure
Comparable Companies
XSAT:PMED OSTO:NEWBRY OSTO:GABA XSAT:DANCAN OSTO:KLAR OSTO:TOL OSTO:VIVE OSTO:ERMA XSAT:ACUC ZTS XTER:MRK LSE:HLN NSE:SUNPHARMA TSE:4502 XSWX:GALD XSWX:SDZ NSE:DIVISLAB HKSE:03692 XTAE:TEVA SHSE:688506
Traded in Other Exchanges
N/A
Address
Ostermalmstorg 1, Stockholm, SWE, 114 42
Website
https://www.odipharma.com
ODI Pharma AB is a provider of medicinal cannabis. It offers its products to pharmacies, specialty clinics, and hospitals.

ODI Pharma AB Headlines

No Headlines